Mark A. Jensen

36.4k total citations · 2 hit papers
57 papers, 4.1k citations indexed

About

Mark A. Jensen is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Mark A. Jensen has authored 57 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Virology and 19 papers in Infectious Diseases. Recurrent topics in Mark A. Jensen's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (16 papers) and Genomics and Phylogenetic Studies (8 papers). Mark A. Jensen is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (16 papers) and Genomics and Phylogenetic Studies (8 papers). Mark A. Jensen collaborates with scholars based in United States, Canada and Germany. Mark A. Jensen's co-authors include Neil A. Straus, John Webster, James I. Mullins, Zhining Wang, Jean C. Zenklusen, David C. Nickle, Daniel Shriner, Angélique B. van ’t Wout, Joseph B. Margolick and Robert L. Grossman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Mark A. Jensen

56 papers receiving 4.0k citations

Hit Papers

Rapid identification of bacteria on the basis of polymera... 1993 2026 2004 2015 1993 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Jensen United States 29 1.6k 1.5k 1.4k 527 398 57 4.1k
Jean‐Pierre Vartanian France 35 2.1k 1.3× 2.0k 1.3× 1.3k 0.9× 1.2k 2.3× 1.5k 3.8× 82 5.0k
Brian Foley United States 34 2.3k 1.4× 1.2k 0.7× 2.1k 1.5× 786 1.5× 663 1.7× 126 4.8k
Noah G. Hoffman United States 30 653 0.4× 1.9k 1.2× 646 0.5× 350 0.7× 851 2.1× 72 3.9k
David C. Nickle United States 38 2.6k 1.6× 1.4k 0.9× 2.3k 1.7× 1.0k 2.0× 1.1k 2.9× 96 5.3k
Lin Li China 27 635 0.4× 944 0.6× 699 0.5× 406 0.8× 319 0.8× 178 2.6k
Joanna L. Shisler United States 30 1.0k 0.6× 930 0.6× 566 0.4× 672 1.3× 1.1k 2.8× 85 3.0k
Xiaojun Wang China 38 764 0.5× 2.5k 1.6× 674 0.5× 800 1.5× 952 2.4× 279 5.4k
Stefano Menzo Italy 27 1.4k 0.8× 640 0.4× 1.4k 1.0× 470 0.9× 805 2.0× 82 3.2k
Kun Luo China 33 1.7k 1.1× 2.9k 1.9× 1.2k 0.9× 1.5k 2.9× 1.2k 3.0× 245 7.3k
Baback Gharizadeh United States 26 382 0.2× 1.4k 0.9× 469 0.3× 334 0.6× 650 1.6× 57 2.8k

Countries citing papers authored by Mark A. Jensen

Since Specialization
Citations

This map shows the geographic impact of Mark A. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Jensen more than expected).

Fields of papers citing papers by Mark A. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Jensen. The network helps show where Mark A. Jensen may publish in the future.

Co-authorship network of co-authors of Mark A. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Jensen. A scholar is included among the top collaborators of Mark A. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Jensen. Mark A. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Weina, Rachael M. Crist, Jeffrey D. Clogston, et al.. (2022). Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory. Advanced Drug Delivery Reviews. 191. 114591–114591. 17 indexed citations
2.
Fitzsimons, Michael, Martin L. Ferguson, Allison P. Heath, et al.. (2017). Developing Cancer Informatics Applications and Tools Using the NCI Genomic Data Commons API. Cancer Research. 77(21). e15–e18. 26 indexed citations
3.
Jensen, Mark A., Vincent Ferretti, Robert L. Grossman, & Louis M. Staudt. (2017). The NCI Genomic Data Commons as an engine for precision medicine. Blood. 130(4). 453–459. 180 indexed citations
4.
Wang, Zhining, Mark A. Jensen, & Jean C. Zenklusen. (2016). A Practical Guide to The Cancer Genome Atlas (TCGA). Methods in molecular biology. 1418. 111–141. 469 indexed citations breakdown →
6.
Swenson, Luke C., Theresa Mo, Winnie Dong, et al.. (2011). Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc. Clinical Infectious Diseases. 53(7). 732–742. 79 indexed citations
7.
Swenson, Luke C., Andrew Low, Alexander Thielen, et al.. (2010). Improved Detection of CXCR4-Using HIV by V3 Genotyping: Application of Population-Based and “Deep” Sequencing to Plasma RNA and Proviral DNA. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 506–510. 66 indexed citations
8.
Swenson, Luke C., Winnie Dong, Xiaolin Zhong, et al.. (2010). Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients. The Journal of Infectious Diseases. 203(2). 237–245. 119 indexed citations
9.
Kandathil, Abraham J., et al.. (2009). A Comparison of Interpretation by Three Different HIV Type 1 Genotypic Drug Resistance Algorithms Using Sequences from Non-Clade B HIV Type 1 Strains. AIDS Research and Human Retroviruses. 25(3). 315–318. 3 indexed citations
10.
Kandathil, Abraham J., et al.. (2009). HIV-1 with Predicted CXCR4 Genotype Identified in Clade C from India. Molecular Diagnosis & Therapy. 13(1). 19–24. 3 indexed citations
11.
Mullins, James I. & Mark A. Jensen. (2006). Evolutionary Dynamics of HIV-1 and the Control of AIDS. Current topics in microbiology and immunology. 299. 171–192. 22 indexed citations
12.
Gottlieb, Geoffrey S., David C. Nickle, Mark A. Jensen, et al.. (2004). Dual HIV-1 infection associated with rapid disease progression. The Lancet. 363(9409). 619–622. 156 indexed citations
13.
Brumme, Zabrina L., Winnie Dong, Benita Yip, et al.. (2004). Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy. AIDS. 18(4). F1–F9. 67 indexed citations
14.
Liu, Yi, David C. Nickle, Daniel Shriner, et al.. (2004). Molecular clock-like evolution of human immunodeficiency virus type 1. Virology. 329(1). 101–108. 13 indexed citations
15.
Jensen, Mark A., Brian Charlesworth, & Martin Kreitman. (2002). Patterns of Genetic Variation at a Chromosome 4 Locus of Drosophila melanogaster and D. simulans. Genetics. 160(2). 493–507. 64 indexed citations
16.
Jensen, Mark A. & H. Gesser. (1999). Influence of inorganic phosphate and energy state on force in skinned cardiac muscle from freshwater turtle and rainbow trout. Journal of Comparative Physiology B. 169(6). 439–444. 7 indexed citations
17.
18.
Jensen, Mark A., et al.. (1991). Improvements in the chain-termination method of DNA sequencing through the use of 7-deaza-2′-deoxyadenosine. DNA sequence. 1(4). 233–239. 6 indexed citations
19.
Trainor, George L. & Mark A. Jensen. (1988). A procedure for the preparation of fluorescence-labeled DNA with terminal deoxynucleotidyl transferase. Nucleic Acids Research. 16(24). 11846–11846. 15 indexed citations
20.
Cummings, Timothy E., Mark A. Jensen, & Philip J. Elving. (1978). Adenine and Cytosine: Basic Polarographic Behavior and Its Interpretation. Bioelectrochemistry and Bioenergetics. 5(1). 239–239. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026